SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
rosyw
Lv1
40 积分
2023-03-21 加入
最近求助
最近应助
互助留言
Low-dose interleukin-2 therapy in autoimmune and inflammatory diseases: facts and hopes
12天前
已完结
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors
17天前
已完结
Beyond Inhibition Against PD-1/PD-L1 Pathway: Development of PD-L1 Inhibitors Targeting Internalization and Degradation of PD-L1
23天前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
1个月前
已完结
An anti-CD98 antibody displaying pH-dependent Fc-mediated tumour-specific activity against multiple cancers in CD98-humanized mice
3个月前
已完结
Computational optimization of antibody humanness and stability by systematic energy-based ranking
3个月前
已完结
FGF21 induces skeletal muscle atrophy and increases amino acids in female mice: a potential role for glucocorticoids
3个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
6个月前
已完结
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
6个月前
已完结
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
10个月前
已完结
没有进行任何应助
速度真快
3个月前
速度真快
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论